LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
VERA Vera Therapeutics
- 41.410
- -1.040-2.45%
Close Dec 27 16:00 ET
- 41.410
- 0.0000.00%
Post 16:20 ET
2.62BMarket Cap-15.87P/E (TTM)
43.060High40.910Low1.80MVolume42.260Open42.450Pre Close74.70MTurnover3.50%Turnover RatioLossP/E (Static)63.32MShares51.61052wk High9.07P/B2.13BFloat Cap14.20052wk Low--Dividend TTM51.45MShs Float51.610Historical High--Div YieldTTM5.07%Amplitude5.200Historical Low41.473Avg Price1Lot Size
Vera Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -60.56%-36.89M | -39.44%-24.78M | -28.67%-33.83M | -36.37%-92.18M | -18.82%-25.14M | -24.72%-22.97M | 6.63%-17.77M | -192.75%-26.29M | -185.12%-67.6M | -228.70%-21.16M |
| Net income from continuing operations | -131.95%-46.63M | -67.19%-33.71M | 5.61%-28.38M | -7.79%-95.99M | 20.91%-25.66M | 18.54%-20.1M | -35.74%-20.16M | -76.00%-30.07M | -173.10%-89.06M | -92.55%-32.44M |
| Depreciation and amortization | 300.00%24K | 189.17%1.5M | -190.32%-1.47M | -382.98%-4.09M | -587.27%-4.1M | 103.95%6K | 587.74%517K | -5,722.22%-506K | -580.68%-846K | -1,965.63%-597K |
| Other non cash items | 11.94%703K | 23.99%889K | -10.71%517K | -62.07%2.22M | -42.97%300K | -85.13%628K | 30.13%717K | 2.66%579K | 46.54%5.86M | -89.21%526K |
| Change In working capital | 219.68%5.86M | 5,242.61%6.14M | -931.15%-8.62M | -186.99%-5.87M | -124.86%-2.12M | -953.55%-4.9M | 101.60%115K | -82.33%1.04M | 92.17%6.75M | 98.88%8.54M |
| -Change in prepaid assets | 11.69%-1.84M | 218.36%2.72M | -110.46%-392K | 102.11%173K | 267.84%809K | -1,255.19%-2.09M | 36.24%-2.3M | 195.10%3.75M | -254.81%-8.18M | -168.27%-482K |
| -Change in payables and accrued expense | 468.51%8M | 20.49%4.03M | -274.70%-7.6M | -117.50%-3.09M | -122.99%-2.24M | -640.30%-2.17M | 226.34%3.35M | -119.95%-2.03M | 200.65%17.64M | 167.36%9.72M |
| -Change in other current assets | 2,809.09%320K | 104.81%13K | 325.00%9K | -178.38%-309K | -253.85%-46K | 116.67%11K | 10.89%-270K | -101.48%-4K | -117.65%-111K | 74.51%-13K |
| -Change in other current liabilities | 5.07%-618K | 6.32%-623K | 6.32%-637K | -1.65%-2.65M | 6.35%-649K | -0.62%-651K | -4.56%-665K | -8.63%-680K | ---2.6M | ---693K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -60.56%-36.89M | -39.44%-24.78M | -28.67%-33.83M | -36.37%-92.18M | -18.82%-25.14M | -24.72%-22.97M | 6.63%-17.77M | -192.75%-26.29M | -185.12%-67.6M | -228.70%-21.16M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 136.12%38.32M | 73.77%-22.68M | -1,892.43%-219.29M | 44.11%-39.43M | 38.10%18.56M | 765.08%16.23M | -105.37%-86.45M | 131.01%12.23M | -1,578.21%-70.55M | 368.74%13.44M |
| Net PPE purchase and sale | ---238K | ---- | ---- | -1.61%-63K | ---63K | --0 | ---- | ---- | ---62K | --0 |
| Net investment purchase and sale | 137.58%38.56M | 73.87%-22.59M | -1,892.43%-219.29M | 44.15%-39.37M | 38.57%18.62M | 775.60%16.23M | -105.40%-86.45M | 131.02%12.23M | ---70.49M | --13.44M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 136.12%38.32M | 73.77%-22.68M | -1,892.43%-219.29M | 44.11%-39.43M | 38.10%18.56M | 765.08%16.23M | -105.37%-86.45M | 131.01%12.23M | -1,578.21%-70.55M | 368.74%13.44M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 148.82%739K | 696.06%3.44M | 156.09%276.54M | 31.01%133.54M | 19.89%24.83M | -67.29%297K | 800.00%432K | 34.53%107.98M | 89.18%101.93M | 320.83%20.71M |
| Net issuance payments of debt | ---- | ---- | ---- | 24.85%24.74M | ---- | ---- | ---- | ---- | 302.68%19.82M | ---- |
| Net common stock issuance | ---13K | --0 | 150.03%287.54M | 33.52%115M | --0 | --0 | --0 | 33.52%115M | 68.30%86.13M | ---1K |
| Proceeds from stock option exercised by employees | 153.20%752K | 696.06%3.44M | 2,779.58%6.91M | -49.30%1.06M | -89.48%87K | -69.54%297K | 819.15%432K | 2.56%240K | 278.73%2.08M | --827K |
| Net other financing activities | --0 | --0 | -146.80%-17.91M | -19.01%-7.26M | --0 | --0 | --0 | -19.03%-7.26M | -120.51%-6.1M | --67K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 148.82%739K | 696.06%3.44M | 156.09%276.54M | 31.01%133.54M | 19.89%24.83M | -67.29%297K | 800.00%432K | 34.53%107.98M | 89.18%101.93M | 320.83%20.71M |
| Net cash flow | ||||||||||
| Beginning cash position | -25.98%25.09M | -49.81%69.11M | 4.41%45.68M | -45.29%43.75M | -10.81%27.44M | -33.18%33.89M | 23.15%137.68M | -45.29%43.75M | 48.10%79.97M | -64.42%30.77M |
| Current changes in cash | 133.67%2.17M | 57.59%-44.02M | -75.06%23.42M | 105.33%1.93M | 40.48%18.24M | 67.68%-6.45M | -69.93%-103.79M | 195.07%93.93M | -239.45%-36.22M | 299.23%12.98M |
| End cash Position | -0.67%27.26M | -25.98%25.09M | -49.81%69.11M | 4.41%45.68M | 4.41%45.68M | -10.81%27.44M | -33.18%33.89M | 23.15%137.68M | -45.29%43.75M | -45.29%43.75M |
| Free cash flow | -61.59%-37.12M | -39.94%-24.87M | -28.67%-33.83M | -36.34%-92.24M | -19.11%-25.21M | -24.46%-22.97M | 6.65%-17.77M | -192.17%-26.29M | -185.38%-67.66M | -228.70%-21.16M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |